Noticias de Eulerpool Arbutus Biopharma

Arbutus Biopharma Noticias de Acciones

Arbutus Biopharma es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Arbutus Biopharma.

• 4 de junio ·

  SeekingAlpha
  Tourlite Capital Q1 2025 Investor Letter
• 31 de mayo ·

  SeekingAlpha
  abrdn Life Sciences Investors Q1 2025 Commentary
• 14 de mayo ·

  Yahoo
  Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates
• 13 de mayo ·

  Yahoo
  Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year?
• 7 de mayo ·

  Yahoo
  Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025
• 25 de abril ·

  Yahoo
  Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?
• 23 de abril ·

  Yahoo
  Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
• 31 de marzo ·

  Yahoo
  All You Need to Know About Arbutus (ABUS) Rating Upgrade to Buy
• 31 de marzo ·

  Yahoo
  Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year?
• 28 de marzo ·

  Yahoo
  Novo gains Lexicon obesity drug; CRISPR COO to step down